Dairy Product Directory

Keep Cydectin out of reach of children.

FOR ALL PRODUCTS: The label contains complete use information, including cautions and warnings. Always read, understand and follow the label, and use directions.

Micotil

Caution: 

Not for animals intended for breeding.

Indications:

Micotil is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni, and for the control of respiratory disease in cattle at high risk of developing BRD associated with M. haemolytica.

IMPORTANT SAFETY INFORMATION:

Before using this product, it is important to read the entire product insert, including the boxed human warning. Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for human use. Injection of this drug in humans has been associated with fatalities. Keep out of reach of children. Administer only with a tube-fed safety syringe. Do not use in automatically powered syringes, single-use syringes, or other delivery devices. Exercise extreme caution to avoid accidental self-injection. In case of human injection, consult a physician immediately and apply ice or cold pack to injection site while avoiding direct contact with the skin. Avoid contact with eyes. Always use proper drug handling procedures to avoid accidental self-injection. Consult your veterinarian on the safe handling and use of all injectable products prior to administration. For use in cattle or sheep only. Inject subcutaneously. Injection of this antibiotic has been shown to be fatal in swine and non-human primates, and may be fatal in horses and goats. Do not use in lambs less than 15 kg body weight. Do not use in female dairy cattle 20 months of age or older. Use in lactating dairy cattle or sheep may cause milk residues. The following adverse reactions have been reported: in cattle: injection site swelling and inflammation, lameness, collapse, anaphylaxis/anaphylactoid reactions, decreased food and water consumption, and death; in sheep: dyspnea and death. Micotil has a pre-slaughter withdrawal time of 42 days.

Baytril 100

Cautions:

Not for human use. Keep out of reach of children. For subcutaneous use in beef cattle and non-lactating dairy cattle.

Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. Federal (U.S.A.) law prohibits the extra-label use of this drug in food-producing animals.

Indications:

Cattle – Single-Dose Therapy: Baytril 100 is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of BRD in beef and non-lactating dairy cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis.

Cattle – Multiple-Day Therapy: Baytril 100 is indicated for the treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni in beef and non-lactating dairy cattle.

Directions for use:

Single-Dose Therapy (BRD Treatment): Administer, by subcutaneous injection, a single dose of 7.5-12.5 mg/kg of body weight (3.4-5.7 mL/100 lbs.).

Multiple-Day Therapy (BRD Treatment): Administer daily, a subcutaneous dose of 2.5-5 mg/kg of body weight (1.1-2.3 mL/100 lbs.).

Treatment should be repeated at 24-hour intervals for three days. Additional treatments may be given on days 4 and 5 to animals that have shown clinical improvement but not total recovery.

Baytril 100 provides flexible subcutaneous injection dosages and durations of therapy.

Do not use in female dairy cattle 20 months of age or older or in calves to be processed for veal.

Talk with your veterinarian to learn more. 

Encore

Directions for use:

Administer one dose in the ear subcutaneously according to label directions.

Increxxa

Indications:

Beef and Non-Lactating Dairy Cattle: Treatment of bovine respiratory disease (BRD)

and control of respiratory disease in cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis. Treatment of infectious bovine

keratoconjunctivitis (IBK) associated with M. bovis. Treatment of bovine foot rot (interdigital necrobacillosis) associated with F. necrophorum and P. levii.

Suckling Calves, Dairy Calves and Veal Calves: Treatment of BRD associated with M.

haemolytica, P. multocida, H. somni and M. bovis.

IMPORTANT SAFETY INFORMATION (ISI):

Not for human use. Keep out of reach of children. Do not use in animals previously found to be hypersensitive to the drug. Increxxa has a pre-slaughter withdrawal time of 18 days. Do not use in female dairy cattle 20 months of age or older.

Rumensin

Caution:

Consumption by unapproved species or feeding undiluted may be toxic or fatal. Do not feed to veal calves.

Directions for use:

Dairy Cows:

For increased milk production efficiency (production of marketable solids-corrected milk per unit of feed intake):

Feeding Directions:

Total Mixed Rations (“complete feed”): Feed continuously to dry and lactating dairy cows a total mixed ration (“complete feed”) containing 11 to 22 g/ton monensin on a 100% dry matter basis.

Component Feeding Systems (including top dress): Feed continuously to dry and lactating dairy cows a Type C Medicated Feed containing 11 to 400 g/ton monensin. The Type C Medicated Feed must be fed in a minimum of 1 pound of feed per cow per day to provide 185 to 660 mg/head/day monensin to lactating cows or 115 to 410 mg/head/day monensin to dry cows. This provides cows with similar amounts of monensin they would receive by consuming total mixed rations containing 11 to 22 g/ton monensin on a 100% dry matter basis.

Growing beef steers and heifers on pasture (stocker, feeder and slaughter) or in a dry lot and replacement beef and dairy heifers:

For increased rate of weight gain: Feed 50 to 200 mg/hd/day in at least 1.0 lb. of Type C Medicated Feed. Or, after the fifth day, feed 400 mg/hd/day every other day in 2.0 lbs. of Type C Medicated Feed. The Type C Medicated Feed must contain 15 to 400 g/ton of monensin (90% DM basis). Do not self-feed.

For the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii: Feed at a rate to provide 0.14 to 0.42 mg/lb. of body weight/day, depending upon the severity of challenge, up to a maximum of 200 mg/hd/day. The Type C Medicated Feed must contain 15 to 400 g/ton of monensin (90% DM basis).

Type C free-choice medicated feeds: All Type C free-choice medicated feeds containing Rumensin must be manufactured according to an FDA-approved formula/specification. When using a formula/specification published in the Code of Federal Regulations (CFR), a Medicated Feed Mill license is not required. Use of Rumensin in a proprietary formula/specification not published in the CFR requires prior FDA approval and a Medicated Feed Mill License.

Do not use Titanium^® BRSV 3, Titanium^® 3 LP, Titanium^® 3, Titanium^® IBR LP and Titanium^® IBR in pregnant cows or in calves nursing pregnant cows. Abortions may result.

Agita, Clean-Up, Corathon, Cydectin, CyLence, Elector, Encore, Elector, Increxxa, Master Guard, Micotil, Neporex, Nuplura, Patriot, Permectrin, QuickBayt, Ravap, Rumensin, Scour Bos, Titanium, Vapona, Vira Shield, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

Baytril is sold by Elanco or its affiliates and is not a Bayer product. The Baytril trademark is owned by Bayer and used under license.

Click to download Micotil Product Label.

Click to download Baytril 100 Product Label.

Click to download Cydectin Dewormer Product Label.

Click to download Increxxa Product Label.